3614143
Last Update Posted: 2018-08-06
Recruiting status is unknown
All Genders accepted | 16 Years-65 Years |
250 Estimated Participants | No Expanded Access |
Observational Study | Does not accept healthy volunteers |
Biomarker Study for Prediction of aGVHD
This is a prospective study in patients receiving allogeneic stem cell transplantation. The blood samples on Day-14, -7, 0 and every 7 days until D100 were collected together with clinical data. In the final analysis, cytokines and biomarkers analysis will be carried out and compared between patients in No aGVHD and grade II-IV aGVHD.
This is a prospective study, observation study in patients receiving allogeneic stem cell transplantation in 4 BMT centers in Shanghai. The blood samples (on Day-14, -7, 0 and every 7 days until D100) and clinical data will be collected. In the final analysis, a panel of cytokines and biomarkers analysis of serial blood samples will be carried out and compared between patients with no aGVHD and grade II-IV aGVHD.
Eligibility
Relevant conditions:
aGVHD
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
Jiong HU, M.D.
hj10709@rjh.com.cn
86-21-64370045
Data sourced from ClinicalTrials.gov